GlobeNewswire Inc.··Not SpecifiedTScan Therapeutics Advances TCR Cell Therapy Pipeline With FDA Clearance, Conference Participation
TScan Therapeutics secures FDA clearance for two IND applications and completes Phase 1 trial enrollment using commercial-scale manufacturing, advancing its TCR cell therapy pipeline.
TCRXclinical-stage biotechsolid tumors